119P Prospective trial of immuno-(chemo)therapy (IO) prior to resection, definitive chemo-radiotherapy, or palliative therapy in patients with borderline resectable non-small cell lung cancer (NSCLC) including oligometastatic disease (KOMPASSneo)

Subjects

Subjects :

Pulmonary and Respiratory Medicine
Oncology

Details

ISSN :

15560864

Volume :

18

Database :

OpenAIRE

Journal :

Journal of Thoracic Oncology

Accession number :

edsair.doi...........bf7592371a955d97fffc9bae529a6ab9

Full Text :

https://doi.org/10.1016/s1556-0864(23)00374-x